Researchers identify peptide produced during cartilage deterioration as a potential source of osteoarthritis pain

April 11, 2018, Rush University Medical Center
Credit: Rush University Medical Center

Osteoarthritis is one of the most common causes of chronic pain in the world. More than 30 million people in the United States alone suffer from osteoarthritis, or OA, which can affect any moveable joint of the body, including the knees, hips and hands. OA normally manifests itself as a breakdown of joint tissues, including degradation of cartilage.

Better treatments for OA are dependent on a clear understanding of how it causes that pain—a question that isn't simple, since cartilage has no neurons (nerve cells) to transmit . Now, an international research team led by an arthritis expert at Rush has shown that a peptide (molecule) produced when cartilage breaks down may drive OA-associated pain.

The researchers are the first to establish a link between the pain and the peptide, which is known as 32-mer, because it is composed of 32 amino acids (organic compounds that are the building blocks of proteins). They reported their discovery March 22 in JCI Insight, a publication of the Journal of Clinical Investigation.

"This is very exciting, because now we can target this process in our efforts to stop the pain," said Dr. Anne-Marie Malfait, who led the project. Malfait is the George W. Stuppy, MD, Chair of Arthritis in Rush Medical College. Malfait and her collaborator and paper co-author, Dr. Amanda Fosang of the University of Melbourne, have grants from the National Institutes of Aging and the U.S. Department of Defense to explore treatments that might block the action of 32-mer in ailing joints.

"We wanted to explore the relationship between the pathological processes that are going on in the degenerating joint and how they relate to pain," she said

When enzymes attack

When OA develops, enzymes in the joint attack aggrecan, a large molecule that is a key component of cartilage. These "aggrecanases", as they're called, split aggrecan at five distinct points, effectively destroying it.

"They chop up the core protein in aggrecan, and fragments of this huge molecule diffuse out of the cartilage," Malfait said. "As a result, the cartilage loses its proper function."

The peptide 32-mer is a by-product of this orchestrated enzymatic attack. Fosang previously discovered that it prompts a response from the immune system.

"Immune cells recognize danger signals in response to invaders like bacteria, but also to threats from pathological processes like joint degeneration under way inside the body," Malfait said. "We decided to see if the 32-mer could be a link between the degenerating joint and the nerves that produce pain."

Discovery may lead to new pain treatments

By comparing the results of a series of experiments in laboratory cultures and on genetically altered laboratory mice that develop OA, the researchers determined that the presence of 32-mer in joints resulted in pain, but only in mice that possessed a normal biochemical signaling pathway resulting from the activation of a receptor on pain-sensing neurons known as Toll-like receptor-2, or TLR2 for short. "That tells us that 32-mer is mediated in the joints through the TLR2 pathway," Malfait said.

This finding will help researchers pinpoint the source of the pain of osteoarthritis, and work toward developing treatments aimed at relieving OA-associated pain. "This is a particularly pressing problem, as drugs that are widely used for the relief of pain in many circumstances such as opiates are problematic to use for chronic diseases like OA, owing to their potential for producing abuse and addiction," Malfait said.

Finding an alternative to the current treatments for OA pain could both avoid a great deal of suffering and save a great amount of money. Treatment of osteoarthritis in the United States cost $130 billion in 2013 (the most recent year for which data is available), according to the federal Centers for Disease Control and Prevention.

Unless more effective, and more cost-effective treatments are found, that expense will increase dramatically by 2030, when nearly 70 million adults in the U.S. will have been diagnosed with some form of arthritis, according to the CDC.

Researchers also are looking for nerves that carry pain signals

However, blocking the action of 32-mer will not prevent osteoarthritis, the paper notes; the peptide is associated with the pain that accompanies the disease, not the degeneration of the joint itself. Malfait also said researchers still don't know the precise location or type of that are responsible for producing in response to 32-mer.

"Answering this question is a key aim for the research program in my laboratory. The nerves are somewhere in the joint, but we don't know exactly where yet," she said.

Explore further: Repurposing anticonvulsants for treatment of injury-induced osteoarthritis

More information: Rachel E. Miller et al. An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2, JCI Insight (2018). DOI: 10.1172/jci.insight.95704

Related Stories

Repurposing anticonvulsants for treatment of injury-induced osteoarthritis

January 3, 2018
Drugs designed for the treatment of central nervous system diseases could also be used to prevent the development of injury-induced arthritis, potentially saving the NHS around half a billion pounds a year.

Researchers find new genes link to arthritis in bone marrow lesions

July 18, 2017
Researchers have found a pattern of genes which is characteristic of osteoarthritis and may be a step towards better treatments for this condition.

Is knee pain linked to depression?

March 23, 2018
In the U.S., about 13 percent of women and 10 percent of men aged 60 or older have knee pain due to osteoarthritis (OA). Osteoarthritis occurs when a joint becomes inflamed, usually because the protective cartilage and other ...

Scientists home in on cause of osteoarthritis pain

December 27, 2012
Researchers at Rush University Medical Center, in collaboration with researchers at Northwestern University, have identified a molecular mechanism central to the development of osteoarthritis (OA) pain, a finding that could ...

If your knee hurts, keep exercising, says expert

March 20, 2018
If you take up exercise later in life, as a treatment for joint or hip pain, you should expect a small, temporary increase in pain. But if you proceed sensibly, you will be rewarded with pain relief similar to that of a non-steroidal ...

New therapeutic targets for osteoarthritis pain

August 26, 2017
A new review by David A. Walsh and Joanne Stocks in the September 2017 issue of SLAS Discovery (formerly the Journal of Biomolecular Screening) explores evolving treatments and future therapies for osteoarthritis (OA) pain.

Recommended for you

Antioxidant found to be effective in treating mice with osteoarthritis

September 14, 2018
A team of researchers in Belgium and the Netherlands has found that feeding a common antioxidant to test mice was effective in treating osteoarthritis. In their paper published in Science Translational Medicine, the group ...

Researchers find answers as to why some people are at risk of gout

September 12, 2018
University of Otago researchers have helped characterise a genetic variant that enables new understanding of why some people are at risk of gout, a painful and debilitating arthritic disease.

Emotions like anger and sadness may cause pain as well as being a result of it

September 10, 2018
While emotions such as anger or sadness are often thought of as being a result of stress or pain, findings recently published by Penn State researchers suggest that negative or mixed emotions could function as stressors themselves.

Dietary carbohydrates could lead to osteoarthritis, new study finds

August 9, 2018
Do your knees ache? According to new findings from the Oklahoma Medical Research Foundation, your diet could be a culprit.

Joint study raises questions about treatments for arthritis

August 3, 2018
A study examining how molecules are transported into knee-joint tissue could have major implications for understanding and treating arthritis.

Researchers identify new arthritis severity gene

July 26, 2018
A new gene associated with disease severity in models of rheumatoid arthritis has been identified by researchers at the Icahn School of Medicine at Mount Sinai. The discovery could provide a new pathway for treatment and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.